Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.41 |
| ▸ | TGM2 | P21980 | 8/20 | 0.40 |
| ▸ | F13A1 | P00488 | 6/20 | 0.40 |
| ▸ | TGM1 | P22735 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7527689 | 0.99 | USP2 (0.42) | USP2SMN1; SMN2CNR2GPR119TGM2 | |
| SCHEMBL2253618 | 0.90 | SMN1; SMN2 (0.46) | USP2SMN1; SMN2TGM2F13A1TGM1 | |
| SCHEMBL6196618 | 0.87 | USP2 (0.44) | USP2SMN1; SMN2GPR119TGM2F13A1 | |
| SCHEMBL2249760 | 0.86 | USP2 (0.51) | USP2SMN1; SMN2TGM2F13A1TGM1 | |
| SCHEMBL960091 | 0.86 | GPR119 (0.43) | USP2SMN1; SMN2GPR119TGM2F13A1 | |
| SCHEMBL30183473 | 0.86 | USP2 (0.43) | USP2SMN1; SMN2GPR119TGM2F13A1 | |
| SCHEMBL5214356 | 0.86 | USP2 (0.43) | USP2SMN1; SMN2GPR119TGM2F13A1 | |
| SCHEMBL961058 | 0.83 | TGM2 (0.43) | USP2SMN1; SMN2GPR119TGM2F13A1 | |
| SCHEMBL26113743 | 0.82 | USP2 (0.45) | USP2SMN1; SMN2GPR119TGM2F13A1 | |
| Hydrochloric Acid SCHEMBL12501570 | 0.81 | USP2 (0.44) | USP2SMN1; SMN2GPR119TGM2F13A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090005375-A1 | ACETYL COENZYME A CARBOXYLASE INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005375-A1 | ACETYL COENZYME A CARBOXYLASE INHIBITORS | ACACA, ACACB, ACAT1 | USP2 731/4885SMN1; SMN2 4276/4885CNR2 3069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.